About Jason Liu, MD

Jason Liu, MD

In the early 2000s, Dr. Liu began his business in the field of biotechnology. He worked and cooperated with a group of experts and scientists in the fields of molecular biology, stem cells, genomics, proteins, and enzymology. Dr. Liu was also involved in the international trade of medical equipment and instruments.

In 2010, he established Amerita Labs, Inc. with his business partner, Mr. Gan Jin. Dr. Liu and his partner have worked with specialists, experts, federal government officers, lawyers, and FDA professionals in the fields of biotechnology and biopharmaceuticals. With tremendous efforts, they extended their biotechnology business globally. The company soon conducted business with many professionals in the USA, as well as China.

In addition to being the president of Amerita Labs, Inc, Dr. Liu is also a business partner of the California-Jiangsu Enterprise Development Group (CJEDG). CJEDG specializes in forging strategic partnerships with the industries of aerospace, advanced agriculture, bio-medicine, business and executive management, environmental protection, executive education, innovation and entrepreneurship, information technology, maritime and ocean science, new energy solutions, and new material productions.

Dr. Jason Liu graduated from Hunan Medical University, Changsha, Hunan, China. He immigrated to the United States in the 1980s. In 1987, Dr. Liu was the clinical investigator and leader of the NIH granted project in the Department of Urology at the University of Michigan, School of Medicine. Dr. Liu completed his post-doctoral training at the Johns Hopkins University School of Medicine, where he served as the primary clinical investigator in the Brady Urological Institute.

Dr. Liu later on switched his career to the IT field, completing his Masters degree in computer science at Towson University. He worked as the Oracle Principal Consultant, and was responsible for the federal government database management of the General Service Administration, Substance Abuse and Mental Health Services Administration, and the United States Coast Guard.

Currently, Dr. Liu’s focus is in the field of biopharmaceuticals. As the president of Amerita Labs, Inc., he is dedicated to the discovery of new innovations in biotechnology and medicine that will ultimately bring China’s biopharmaceutical business to the world class level.

 

刘建湘博士简历

            在2000年代初期,刘建湘博士开始生物科技领域的商业运作。他集结一大批专家,科学家,涉及到分子生物学,干细胞学,基因学,蛋白质学,及酶学的广泛领域。他的商业运作还涉及医疗器械的国际贸易领域。

            2010年,刘博士与其合作伙伴金敢先生创立了阿美利达生物医药技术有限公司,任该公司总裁。在生物科技及生物制药领域里,他和金先生与许多专家,科学家,联邦官员,律师,及FDA专家进行广泛合作。通过艰苦努力,和许多一流专家一道,将先进生物制药技术引进中国。

            除了担任阿美利达生物医药技术有限公司总裁之外,刘博士还担任加州江苏企业开发集团董事。该集团公司的业务涵盖航空航天,现代农业,生物制药,商务及企业管理,环境保护,IT行业,行政教育创新及创业,海事及海洋科学,新能源,新材料等领域。

            刘建湘博士毕业于湖南医科大学,1980年代移民美国。1987年,刘博士在密西根大学医学院任临床研究员,负责NIH的研究项目。此后在霍普金斯大学医学院完成博士后训练,并在该院担任临床研究员。

            随后,刘博士进入IT行业。他在陶森大学完成计算机科学硕士训练。不久,作为Oracle公司的高级咨询师,负责内务部,商业部, 卫生部,及海岸警卫队等联邦机构的大型资料库的运作和管理。

            目前,刘博士仍致力于生物制药领域。他不遗余力,将世界一流生物科技及一流精英人才引进中国,打造世界一流的中国生物制药业。